Notification for sale of treasury shares - komunikat spółki SOPHARMA AD (sopharma) - komunikat ESPI

Komunikat spółki

COMMON REPORT

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		206	/	2025
	Date of issue:		2025-10-23
	Short name of the issuer
	SOPHARMA AD
	Subject
	Notification for sale of treasury shares
	Official market - legal basis
	Art. 56. 1. 2 of Act on Public Offering
	Unofficial market - legal basis
	Contents of the report:
	Sofia, Bulgaria According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on October 22, 2025 the Company sold 6 866 (six thousand eight hundred and sixty-six) treasury shares representing 0.001% of the share capital of the Company, at a total value of BGN 18 582.20 on the Bulgarian Stock Exchange, the average price per share was BGN 2.71. The total number of treasury shares after this transaction is 19 694 145 representing 3.65% of the share capital of the Company.
	Annexes
	File				Description
	Current report_206_treasury_shares_espi.pdf				Notification for sale of treasury shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2025-10-23	Ognian Ivanov Donev	Executive Director

Nazwa jednostki:	SOPHARMA AD
Nazwa skrócona jednoskti:	SOPHARMA AD
Adres:	IlienskoShosse 16, 1220 Sofia
Telefon:	+359 2 813 42 00
Fax:	+359 2 936 02 86
NIP:	nd